Author

S. Zilberzwige-Tal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

D. Gazit· 1 shared D. Laor· 1 shared E. Gazit· 1 shared H. Adsi· 1 shared M. Gartner· 1 shared R. Behl· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

D. Gazit

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintMay 16, 2022

Engineered Riboswitch Nano-carriers as a Possible Disease-Modifying Treatment for Metabolic Disorders

S. Zilberzwige-Tal, D. Gazit, H. Adsi…·E. Gazit

This paper engineers RNA-virus-like nanocarriers with riboswitches to treat metabolic disorders by inhibiting metabolite self-assembly and reducing amyloid-like structures in yeast.

DOI 10.1101/2022.05.16.492066

yeastDNA methylation

𝕏 PostBluesky